Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
0.7100
-0.0048 (-0.67%)
At close: May 13, 2025, 4:00 PM
0.7333
+0.0233 (3.28%)
Pre-market: May 14, 2025, 8:22 AM EDT
Nektar Therapeutics Employees
Nektar Therapeutics had 61 employees as of December 31, 2024. The number of employees decreased by 76 or -55.47% compared to the previous year.
Employees
61
Change (1Y)
-76
Growth (1Y)
-55.47%
Revenue / Employee
$1,430,295
Profits / Employee
-$2,181,000
Market Cap
132.13M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NKTR News
- 16 hours ago - Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference - PRNewsWire
- 5 days ago - Nektar Therapeutics (NKTR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Nektar Therapeutics Reports First Quarter 2025 Financial Results - PRNewsWire
- 12 days ago - Nektar to Announce Financial Results for the First Quarter on Thursday, May 8, 2025, After Close of U.S.-Based Financial Markets - PRNewsWire
- 7 weeks ago - Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference - PRNewsWire
- 2 months ago - Nektar Therapeutics (NKTR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire
- 2 months ago - Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets - PRNewsWire